(19)
(11) EP 4 572 783 A1

(12)

(43) Date of publication:
25.06.2025 Bulletin 2025/26

(21) Application number: 23782895.9

(22) Date of filing: 29.09.2023
(51) International Patent Classification (IPC): 
A61K 38/26(2006.01)
 A61P 1/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/26; A61P 1/00
(86) International application number:
PCT/EP2023/077065
(87) International publication number:
WO 2024/068933 (04.04.2024 Gazette 2024/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 30.09.2022 US 202263377868 P

(71) Applicant: Zealand Pharma A/S
2860 Søborg (DK)

(72) Inventors:
  • AGERSNAP, Mikkel Askjaer
    2860 Søborg (DK)
  • NIELSEN, Thor Schütt Svane
    2860 Søborg (DK)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES AND THEIR MEDICAL USES FOR THE TREATMENT OF SHORT BOWEL SYNDROME (SBS)